Evolocumab for prevention of coronary artery bypass failure: timing is everything. Gaudino M, Sandner S. Lancet 2025 Aug 28:S0140-6736(25)01718-0. doi: 10.1016/S0140-6736(25)01718.

Read + Share

Amedeo Smart

Independent Medical Education

Gaudino M, Sandner S. Evolocumab for prevention of coronary artery bypass failure: timing is everything. Lancet 2025 Aug 28:S0140-6736(25)01718-0. doi: 10.1016/S0140-6736(25)01718.
PMID: 40907503